These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21453479)

  • 1. Immunological network signatures of cancer progression and survival.
    Clancy T; Pedicini M; Castiglione F; Santoni D; Nygaard V; Lavelle TJ; Benson M; Hovig E
    BMC Med Genomics; 2011 Mar; 4():28. PubMed ID: 21453479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling networks of distinct immune-cells in tumors.
    Clancy T; Hovig E
    BMC Bioinformatics; 2016 Jul; 17(1):263. PubMed ID: 27377892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of immune gene signatures in solid tumors and prognostic implications.
    Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
    BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biomarker discovery: the entropic hallmark.
    Berretta R; Moscato P
    PLoS One; 2010 Aug; 5(8):e12262. PubMed ID: 20805891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Profiling of Deficient Mismatch Repair Colorectal Cancer Tumor Microenvironment Reveals Different Levels of Immune System Activation.
    Giannini R; Zucchelli G; Giordano M; Ugolini C; Moretto R; Ambryszewska K; Leonardi M; Sensi E; Morano F; Pietrantonio F; Cremolini C; Falcone A; Fontanini G
    J Mol Diagn; 2020 May; 22(5):685-698. PubMed ID: 32173570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
    Pan H; Lu L; Cui J; Yang Y; Wang Z; Fan X
    Aging (Albany NY); 2020 Jan; 12(2):1446-1464. PubMed ID: 31954372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis.
    Wang X; Chai Z; Li Y; Long F; Hao Y; Pan G; Liu M; Li B
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways.
    Hoang TH; Zhao Y; Lam Y; Piekos S; Han YC; Reilly C; Joshi P; Hong SH; Sung CO; Giardina C; Shin DG
    Sci Rep; 2019 Jun; 9(1):9029. PubMed ID: 31227749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
    Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
    Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic landscape of adaptive immune resistance signatures and infiltrating immune cells in the tumor microenvironment of uveal melanoma.
    Wang Y; Xu Y; Dai X; Lin X; Shan Y; Ye J
    Exp Eye Res; 2020 Jul; 196():108069. PubMed ID: 32439398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors.
    Nirmal AJ; Regan T; Shih BB; Hume DA; Sims AH; Freeman TC
    Cancer Immunol Res; 2018 Nov; 6(11):1388-1400. PubMed ID: 30266715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Reprogramming of Immune Cells in Cancer Progression.
    Biswas SK
    Immunity; 2015 Sep; 43(3):435-49. PubMed ID: 26377897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.
    Zuo S; Wei M; Wang S; Dong J; Wei J
    Front Immunol; 2020; 11():1218. PubMed ID: 32714316
    [No Abstract]   [Full Text] [Related]  

  • 14. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.
    Li B; Severson E; Pignon JC; Zhao H; Li T; Novak J; Jiang P; Shen H; Aster JC; Rodig S; Signoretti S; Liu JS; Liu XS
    Genome Biol; 2016 Aug; 17(1):174. PubMed ID: 27549193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Cell-Type Deconvolution Methods in Cancer Immunotherapy.
    Sturm G; Finotello F; List M
    Methods Mol Biol; 2020; 2120():213-222. PubMed ID: 32124322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
    de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
    Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.
    Marzagalli M; Ebelt ND; Manuel ER
    Semin Cancer Biol; 2019 Dec; 59():236-250. PubMed ID: 31404607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining TCGA Database for Tumor Microenvironment-Related Genes of Prognostic Value in Hepatocellular Carcinoma.
    Deng Z; Wang J; Xu B; Jin Z; Wu G; Zeng J; Peng M; Guo Y; Wen Z
    Biomed Res Int; 2019; 2019():2408348. PubMed ID: 31828095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.